Lorna Collings

ALSA Ventures thesis

Our approach Our investment approach is primarily focused around therapeutics. We look for novel drugs and modalities in a wide variety of disease areas, and invest across the spectrum of drug development. We are equally comfortable in company formation as we are in participating in syndicates with co-investors. Our process is heavily reliant on proprietary deal flow. With a rich history of working with hundreds of biotech companies and entrepreneurial teams in past lives, our team is particularly well networked globally to identify and evaluate novel, exciting breakthroughs. Once invested, we

Sector and stage focus

• Seed: Pharmaceuticals, BioTech, Chemicals
• general: London
• Pre-seed: Pharmaceuticals, Chemicals, BioTech

Is Lorna Collings a fit for your round?

Upload your pitch deck and see whether Lorna Collings appears in your top 20 matches.